These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 10447943

  • 1. Synthesis and enantiomeric separation of 2-phthalimidino-glutaric acid analogues: potent inhibitors of tumor metastasis.
    Shah JH, Swartz GM, Papathanassiu AE, Treston AM, Fogler WE, Madsen JW, Green SJ.
    J Med Chem; 1999 Aug 12; 42(16):3014-7. PubMed ID: 10447943
    [No Abstract] [Full Text] [Related]

  • 2. Synthesis and antitumor effect in vitro and in vivo of substituted 1,3-dihydroindole-2-ones.
    Christensen MK, Erichsen KD, Trojel-Hansen C, Tjørnelund J, Nielsen SJ, Frydenvang K, Johansen TN, Nielsen B, Sehested M, Jensen PB, Ikaunieks M, Zaichenko A, Loza E, Kalvinsh I, Björkling F.
    J Med Chem; 2010 Oct 14; 53(19):7140-5. PubMed ID: 20845961
    [Abstract] [Full Text] [Related]

  • 3. Antitumor activity of substituted E-3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones1.
    Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Varoli L, Kunkel MW.
    J Med Chem; 2006 Nov 16; 49(23):6922-4. PubMed ID: 17154522
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
    Amishiro N, Okamoto A, Murakata C, Tamaoki T, Okabe M, Saito H.
    J Med Chem; 1999 Jul 29; 42(15):2946-60. PubMed ID: 10425104
    [Abstract] [Full Text] [Related]

  • 5. Cell differentiation inducers derived from thalidomide.
    Noguchi T, Miyachi H, Katayama R, Naito M, Hashimoto Y.
    Bioorg Med Chem Lett; 2005 Jul 01; 15(13):3212-5. PubMed ID: 15936192
    [Abstract] [Full Text] [Related]

  • 6. 4- and 5-aroylindoles as novel classes of potent antitubulin agents.
    Liou JP, Wu CY, Hsieh HP, Chang CY, Chen CM, Kuo CC, Chang JY.
    J Med Chem; 2007 Sep 06; 50(18):4548-52. PubMed ID: 17685504
    [Abstract] [Full Text] [Related]

  • 7. A novel anticancer effect of thalidomide: inhibition of intercellular adhesion molecule-1-mediated cell invasion and metastasis through suppression of nuclear factor-kappaB.
    Lin YC, Shun CT, Wu MS, Chen CC.
    Clin Cancer Res; 2006 Dec 01; 12(23):7165-73. PubMed ID: 17145842
    [Abstract] [Full Text] [Related]

  • 8. Amino derivatives of indole as potent inhibitors of isoprenylcysteine carboxyl methyltransferase.
    Go ML, Leow JL, Gorla SK, Schüller AP, Wang M, Casey PJ.
    J Med Chem; 2010 Oct 14; 53(19):6838-50. PubMed ID: 20809634
    [Abstract] [Full Text] [Related]

  • 9. Novel antitumor agent family of 1H-benzo[c,d]indol-2-one with flexible basic side chains: synthesis and biological evaluation.
    Yin H, Xu Y, Qian X.
    Bioorg Med Chem; 2007 Feb 01; 15(3):1356-62. PubMed ID: 17129733
    [Abstract] [Full Text] [Related]

  • 10. A novel class of in vivo active anticancer agents: achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065.
    Sato A, McNulty L, Cox K, Kim S, Scott A, Daniell K, Summerville K, Price C, Hudson S, Kiakos K, Hartley JA, Asao T, Lee M.
    J Med Chem; 2005 Jun 02; 48(11):3903-18. PubMed ID: 15916443
    [Abstract] [Full Text] [Related]

  • 11. Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity.
    Komatsu Y, Tomizaki KY, Tsukamoto M, Kato T, Nishino N, Sato S, Yamori T, Tsuruo T, Furumai R, Yoshida M, Horinouchi S, Hayashi H.
    Cancer Res; 2001 Jun 01; 61(11):4459-66. PubMed ID: 11389076
    [Abstract] [Full Text] [Related]

  • 12. CC-1065 analogues bearing different DNA-binding subunits: synthesis, antitumor activity, and preliminary toxicity study.
    Wang Y, Li L, Ye W, Tian Z, Jiang W, Wang H, Wright SC, Larrick JW.
    J Med Chem; 2003 Feb 13; 46(4):634-7. PubMed ID: 12570384
    [Abstract] [Full Text] [Related]

  • 13. Novel arylsulfoanilide-oxindole hybrid as an anticancer agent that inhibits translation initiation.
    Natarajan A, Guo Y, Harbinski F, Fan YH, Chen H, Luus L, Diercks J, Aktas H, Chorev M, Halperin JA.
    J Med Chem; 2004 Oct 07; 47(21):4979-82. PubMed ID: 15456240
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and antiproliferative activity in vitro of novel (2-butynyl)thioquinolines.
    Mól W, Matyja M, Filip B, Wietrzyk J, Boryczka S.
    Bioorg Med Chem; 2008 Sep 01; 16(17):8136-41. PubMed ID: 18682326
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis and biological evaluation of N-heterocyclic indolyl glyoxylamides as orally active anticancer agents.
    Li WT, Hwang DR, Chen CP, Shen CW, Huang CL, Chen TW, Lin CH, Chang YL, Chang YY, Lo YK, Tseng HY, Lin CC, Song JS, Chen HC, Chen SJ, Wu SH, Chen CT.
    J Med Chem; 2003 Apr 24; 46(9):1706-15. PubMed ID: 12699388
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.